Future of Medicine: Surgical Robotics, Evidence and Training

Robot-assisted surgery has moved from a few pioneering centres to a standard option for many procedures in urology, gynaecology, colorectal and general surgery. Its marketing often runs ahead of its evidence, though, and the word "robot" invites misunderstanding.

What a surgical robot is, and is not

The FDA describes robotically-assisted surgical devices as computer-assisted surgical systems that enable a surgeon to use computer and software technology to control and move surgical instruments through one or more tiny incisions. In the common design, the surgeon sits at a console, views a magnified three-dimensional image and controls instruments mounted on robotic arms at the bedside.

Key points:

• The surgeon is in control. Current systems do not decide or act independently; they translate the surgeon's hand movements.
• It is minimally invasive surgery. Robotic surgery is a form of laparoscopic or thoracoscopic surgery with added dexterity, tremor filtering and 3D vision.
• A bedside team is essential. Assistants manage ports, instruments and any conversion to open surgery.

The FDA states that the safety and effectiveness of these devices has not been established for all procedures, and that patients and clinicians should understand the risks and benefits compared with other approaches.

What the trials actually show

The strongest evidence comes from randomised trials comparing robot-assisted surgery with either open surgery or conventional laparoscopy. Results are more modest than the hype.

Rectal cancer: ROLARR

The ROLARR trial randomised patients with rectal cancer to robot-assisted or conventional laparoscopic resection, performed by surgeons experienced in each technique. The primary outcome was conversion to open laparotomy. Robotic surgery did not significantly reduce the risk of conversion compared with laparoscopy. Secondary outcomes, including complications and pathological margins, were also broadly similar.

Prostate cancer: robot vs open

A randomised phase 3 trial in Australia compared robot-assisted laparoscopic prostatectomy with open radical retropubic prostatectomy performed by a single experienced surgeon in each arm. Urinary and sexual function at 12 weeks were similar between groups. The authors suggested patients should choose an experienced surgeon rather than a particular technology.

These trials do not mean robots are useless. Surgeons report ergonomic advantages, and robots may make complex minimally invasive operations accessible to more surgeons, particularly in a narrow pelvis. But the advantage over a skilled laparoscopic or open surgeon is procedure-specific and has to be proven, not assumed.

Costs and system questions

Robotic platforms involve purchase, maintenance and instrument costs, and they need trained teams and operating time. Health systems therefore ask:

• Which procedures show clear patient benefit, such as shorter stay or fewer conversions?
• Can volume be high enough to keep surgeons and teams proficient?
• Does robotic access shift surgery from open to minimally invasive in a way that benefits patients?
• How is training funded and credentialed?

For any specific procedure or hospital, local outcome data and guidance matter more than headlines.

Autonomy: what research has shown

The STAR (Smart Tissue Autonomous Robot) research system performed laparoscopic intestinal anastomosis autonomously in pigs. The robot used advanced 3D imaging and planning to place sutures, and its results compared favourably with surgeon-performed anastomoses in that experimental setting.

What this does and does not mean:

• It shows that a specific, well-defined task can be automated in an animal model.
• It does not mean autonomous robots are performing human operations routinely.
• Clinical use would require extensive human trials and regulatory review of a kind not yet completed for autonomous soft-tissue surgery.

A realistic near-term path is partial automation: software that assists with camera control, suturing tension, image overlay or warnings about critical structures, while the surgeon remains in charge.

Robots plus imaging and AI

Several trends connect surgical robotics with other parts of this series:

• Image guidance. Overlaying preoperative CT or MRI on the live view could help locate tumours and vessels.
• Video analysis. Recorded console video can be used for skill assessment, coaching and research.
• Telesurgery. Remote surgery across long distances has been demonstrated, but latency, connectivity, licensing and liability remain major hurdles.

See AI in diagnostics for the regulatory principles that also apply to AI features in surgical systems.

What it means for surgical training

Robotic surgery changes how surgeons learn.

Simulation first

Console skills can be practised on virtual reality simulators before touching a patient. The broader evidence base for VR in surgery dates back to a randomised, double-blinded study showing that residents trained on a VR simulator performed laparoscopic gallbladder dissection faster and with fewer errors than controls. Read more in VR and simulation in medical training.

A typical robotic training pathway

1. Online modules on the platform and its safety features.
2. Simulator exercises with performance scores.
3. Dry-lab and wet-lab practice with the actual system.
4. Bedside assisting to learn docking, ports and troubleshooting.
5. Proctored console cases, starting with parts of procedures.
6. Hospital credentialing and ongoing case volume requirements.

The open-surgery skills question

A recurring concern is that trainees who learn mainly robotic techniques may get less exposure to open surgery, which is still needed for emergencies and conversions. Training programmes are working to balance both.

What medical students should take away

• Surgical anatomy, physiology and perioperative medicine remain the foundation regardless of the tool.
• Evaluate claims like any other intervention: randomised evidence, relevant outcomes, cost and surgeon experience.
• If you are interested in surgery, seek simulator time early and learn the basics of minimally invasive principles.

Licensing exams test the same foundations: anatomy, complications, perioperative management and evidence appraisal. The MediFlow app offers exam-style questions in surgery and the basic sciences to keep those fundamentals sharp.

What patients ask, and how to answer honestly

Clinicians and students on surgical placements are often asked about robots. Honest, evidence-based answers help patients make informed choices:

• "Is the robot doing the operation?" No. The surgeon controls every movement from a console; the system translates and scales those movements.
• "Is it safer?" It depends on the procedure. For some operations trials show similar outcomes to laparoscopic or open surgery. The surgeon's and the team's experience matter a great deal.
• "Will I recover faster?" Minimally invasive approaches, robotic or laparoscopic, often mean smaller incisions. Whether robotic surgery adds benefit over conventional laparoscopy varies by operation.
• "What if something goes wrong with the machine?" Teams train for system faults and conversion to laparoscopic or open surgery. The FDA encourages reporting of device problems through its adverse event systems.

Questions a hospital should answer before adopting a platform

• Which procedures and patient groups will use it, and what outcome improvement is expected?
• How many cases per surgeon and team are needed to maintain proficiency?
• How will trainees continue to gain open and laparoscopic experience?
• How will outcomes be audited and compared with previous practice?
• What is the full cost per case, including instruments, maintenance and theatre time?
• How will patients be informed about alternatives?

Common misconceptions

• "Robots mean better outcomes." Randomised evidence is procedure-specific and often shows similar results.
• "Autonomous surgery is imminent." Autonomy has been shown for defined tasks in animal studies, not routine human surgery.
• "Simulator scores equal competence." Simulators build basic skills; proctored real cases and credentialing remain essential.

Outlook

Surgical robots are here to stay, and newer, smaller and cheaper platforms are entering the market. The key questions for the next decade are which procedures truly benefit, how to train and credential surgeons efficiently, how to integrate imaging and AI safely, and whether autonomy can move from animal studies to carefully regulated human use. The evidence so far argues for enthusiasm tempered by data.

Continue with how medical jobs will change.